These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 1164407

  • 1. Combination chemotherapy in Hodgkin's disease: relation to radiotherapy.
    Rosenberg SA.
    Bibl Haematol; 1975; (40):731-5. PubMed ID: 1164407
    [Abstract] [Full Text] [Related]

  • 2. A comparison of nitrogen mustard, vincristine, procarbazine, and prednisone (MOPP) vs. nitrogen mustard in advanced Hodgkin's disease.
    Huguley CM, Durant JR, Moores RR, Chan YK, Dorfman RF, Johnson L.
    Cancer; 1975 Oct; 36(4):1227-40. PubMed ID: 1175125
    [Abstract] [Full Text] [Related]

  • 3. The management of stages I, II, and III Hodgkin's disease with combined radiotherapy and chemotherapy.
    Rosenberg SA, Kaplan HS.
    Cancer; 1975 Jan; 35(1):55-63. PubMed ID: 803252
    [Abstract] [Full Text] [Related]

  • 4. Value of prednisone in combination chemotherapy of stage IV Hodgkin's disease. Report from the British National Lymphoma Investigation.
    Br Med J; 1975 Aug 16; 3(5980):413-4. PubMed ID: 1098721
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [81 cases of Hodgkin's disease treated with extensive radiotherapy, including 65 with primary MOPP chemiotherapy (author's transl)].
    Baillet F, Brun B, Maylin C, Mazeron JJ, Pierquin B, Dreyfus B.
    J Radiol Electrol Med Nucl; 1977 May 16; 58(5):343-6. PubMed ID: 886528
    [Abstract] [Full Text] [Related]

  • 10. Combination chemotherapy and survival in advanced Hodgkin's disease.
    Canellos GP, Young RC, Berard CW, DeVita VT.
    Arch Intern Med; 1973 Mar 16; 131(3):388-90. PubMed ID: 4569375
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. MOPP chemotherapy for advanced Hodgkin's disease. Prognostic factors in 81 patients.
    Moore MR, Jones SE, Bull JM, William LA, Rosenberg SA.
    Cancer; 1973 Jul 16; 32(1):52-60. PubMed ID: 4716784
    [No Abstract] [Full Text] [Related]

  • 17. Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial.
    Duggan DB, Petroni GR, Johnson JL, Glick JH, Fisher RI, Connors JM, Canellos GP, Peterson BA.
    J Clin Oncol; 2003 Feb 15; 21(4):607-14. PubMed ID: 12586796
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A Southwest Oncology Group: chemotherapy versus chemotherapy plus radiotherapy in treatment of stage III Hodgkin's disease.
    Grozea PN, De Persio EJ, Coltman CA, Fabian CJ, Morrison FS, Gehan EA, Jones SE.
    Recent Results Cancer Res; 1982 Feb 15; 80():83-91. PubMed ID: 6173904
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.